NeuroMetrix Inc logo

NeuroMetrix Inc

$ 2.79 -0.07 (-2.45%) 04:00 PM EST
P/E:
At Loss
P/B:
0.87
Market Cap:
$ 20.03M
Enterprise V:
$ -2.17M
Volume:
22.48K
Avg Vol (2M):
102.34K
Also Trade In:
Volume:
22.48K
Market Cap $:
20.03M
PE Ratio:
At Loss
Avg Vol (2-Month):
102.34K
Enterprise Value $:
-2.17M
PB Ratio:
0.87
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.
Name Current Vs Industry Vs History
Cash-To-Debt 56.43
Equity-to-Asset 0.93
Debt-to-Equity 0.02
Debt-to-EBITDA -0.11
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.6
Distress
Grey
Safe
Beneish M-Score -2.17
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.16
9-Day RSI 30.34
14-Day RSI 34.63
6-1 Month Momentum % -25.4
12-1 Month Momentum % -68.76

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.51
Quick Ratio 14.96
Cash Ratio 14.46
Days Inventory 131.66
Days Sales Outstanding 23.14
Days Payable 50.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -108.4

Financials (Next Earnings Date:2022-10-21 Est.)

NURO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NURO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8.324
EPS (TTM) ($) -0.58
Beta 3.08
Volatility % 68.07
14-Day RSI 34.63
14-Day ATR ($) 0.195142
20-Day SMA ($) 3.195375
12-1 Month Momentum % -68.76
52-Week Range ($) 2.7 - 10.34
Shares Outstanding (Mil) 7.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NeuroMetrix Inc Filings

Document Form Filing Date
No Filing Data

NeuroMetrix Inc Analysis

Share your research

Headlines

See More
No news.